The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
Open accessAbstract
Recent data indicate that ceramide (Cer) and lysophosphatidylcholine (LPC) regulate immune cell functions. Since these bioactive lipids are generated in blood plasma by inflammatory lipases, we hypothesized that they may be involved in the process of acute systemic sepsis. In order to provide support for this hypothesis, we analyzed the plasma levels of Cer and LPC by quantitative tandem mass spectrometry in 102 sepsis patients starting with the day at which the sepsis criteria were fulfilled for the first time, as well as on day 4 and day 11. The values were compared with 56 healthy controls and correlated with sepsis-related mortality within 30 days of study entry. Most Cer species were increased in sepsis patients, while all LPC species were markedly decreased. In addition, we determined the molar ratios with their precursor molecules sphingomyelin (SPM) and phosphatidylcholine (PC), which reflect the enzymatic reactions responsible for their formation. Species-specific as well as total Cer-SPM ratios were increased, whereas LPC-PC ratios were decreased in sepsis patients. The increased Cer-SPM ratios as well as the decreased LPC-PC ratios showed a strong predictive power for sepsis-related mortality. Together with existing data from in vitro experiments and animal models, the results provide the first ex vivo indication for the role of Cer and lysophospholipids in systemic inflammation in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001) · Science · doi:10.1126/science.1061781 · Cited by 332
RetractedA RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Kume, N., Cybulsky, M. I., & Gimbrone, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115932 · Cited by 824
Manual of Clinical Microbiology
Kepler, J. A. (1975) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/32.4.438 · Cited by 497
Pfeiffer, A., Böttcher, A., Orsó, E., Kapinsky, M., Nagy, P., Bodnár, A., Spreitzer, I., Liebisch, G., Drobnik, W., Gempel, K., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3153::aid-immu3153>3.0.co;2-0 · Cited by 401
Self-citationKume, N., & Gimbrone, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117047 · Cited by 329
Cited by
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
“Serum ceramide levels are increased in animals treated with LPS and in patients with sepsis (128, 169, 170).”
Han, X., & Gross, R. W. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,106
Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
Engulfment of apoptotic cells: signals for a good meal
Ravichandran, K. S., & Lorenz, U. (2007) · Nature Reviews Immunology · doi:10.1038/nri2214 · Cited by 637
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
Langley, R. J., Tsalik, E. L., Velkinburgh, J. C. V., Glickman, S. W., Rice, B. J., Wang, C., Chen, B., Carin, L., Suarez, A., Mohney, R. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005893 · Cited by 507
Emerging roles of lysophospholipids in health and disease
Tan, S. T., Ramesh, T., Toh, X. R., & Nguyen, L. N. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101068 · Cited by 371
Wiesner, P., Leidl, K., Boettcher, A., Schmitz, G., & Liebisch, G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d800028-jlr200 · Cited by 363
Self-citationMetabolism and atherogenic disease association of lysophosphatidylcholine
Schmitz, G., & Ruebsaamen, K. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.029 · Cited by 357
Self-citationBrancucci, N. M. B., Gerdt, J. P., Wang, C., De Niz, M., Philip, N., Adapa, S. R., Zhang, M., Hitz, E., Niederwieser, I., Boltryk, S. D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.020 · Cited by 346
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Liebisch, G., Lieser, B., Rathenberg, J., Drobnik, W., & Schmitz, G. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.09.003 · Cited by 336
Self-citationTherapeutic effects of lysophosphatidylcholine in experimental sepsis
Yan, J.-J., Jung, J.-S., Lee, J.-E., Lee, J., Huh, S.-O., Kim, H.-S., Jung, K. C., Cho, J.-Y., Nam, J.-S., Suh, H.-W., et al. (2004) · Nature Medicine · doi:10.1038/nm989 · Cited by 329
Characterization of overall ceramide species in human stratum corneum
Masukawa, Y., Narita, H., Shimizu, E., Kondo, N., Sugai, Y., Oba, T., Homma, R., Ishikawa, J., Takagi, Y., Kitahara, T., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800014-jlr200 · Cited by 322
Blood sphingolipidomics in healthy humans: impact of sample collection methodology
Hammad, S. M., Pierce, J. S., Soodavar, F., Smith, K. J., Al Gadban, M. M., Rembiesa, B., Klein, R. L., Hannun, Y. A., Bielawski, J., & Bielawska, A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.d008532 · Cited by 314
Zhao, X., Peter, A., Fritsche, J., Elcnerova, M., Fritsche, A., Häring, H.-U., Schleicher, E. D., Xu, G., & Lehmann, R. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90748.2008 · Cited by 170
Association of ceramides in human plasma with risk factors of atherosclerosis
Ichi, I., Nakahara, K., Miyashita, Y., Hidaka, A., Kutsukake, S., Inoue, K., Maruyama, T., Miwa, Y., Harada‐Shiba, M., Tsushima, M., et al. (2006) · Lipids · doi:10.1007/s11745-006-5041-6 · Cited by 96
Lin, M., Xu, F., Sun, J., Song, J., Shen, Y., Lu, S., Ding, H., Lan, L., Chen, C., Ma, W., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05000-3 · Cited by 38
“In sepsis patients, serum LysoPC levels were lower than those in controls, and among them, LysoPC (16:0) and LysoPC (18:0) were decreased [40].”
BackgroundJakobsson, J. E., Menezes, J., Krock, E., Hunt, M. A., Carlsson, H., Vaivade, A., Emami Khoonsari, P., Agalave, N. M., Sandström, A., Kadetoff, D., et al. (2025) · The Journal of Pain · doi:10.1016/j.jpain.2025.105331 · Cited by 9
Orešič, M., Seppänen-Laakso, T., Sun, D., Tang, J., Therman, S., Viehman, R., Mustonen, U., van Erp, T. G., Hyötyläinen, T., Thompson, P., et al. (2012) · Genome Medicine · doi:10.1186/gm300 · Cited by 5
“Recent research in sepsis has also shown that lysoPC inversely correlates with the severity of infection [44] and that lysoPC administration to mouse models of sepsis protects them against lethality [45].”
Background
Metadata
- Authors
- Drobnik, W., Liebisch, G., Audebert, F.-X., Fröhlich, D., Glück, T., Vogel, P., Rothe, G., & Schmitz, G.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 44
- Issue
- 4
- Pages
- 754-761
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2062780075
- Cited by
- 350
- References
- 29
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.